BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 36970340)

  • 1. Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease.
    Xi H; Liu J; Xu T; Li Z; Mou X; Jin Y; Xia S
    Front Cardiovasc Med; 2023; 10():1117915. PubMed ID: 36970340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention.
    He W; Xu C; Wang X; Lei J; Qiu Q; Hu Y; Luo D
    BMC Cardiovasc Disord; 2021 Sep; 21(1):435. PubMed ID: 34521385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Nomogram for Predicting In-Stent Restenosis Risk in Patients Undergoing Percutaneous Coronary Intervention: A Population-Based Analysis.
    Luo Y; Tan N; Zhao J; Li Y
    Int J Gen Med; 2022; 15():2451-2461. PubMed ID: 35264881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Value Analysis of in-Stent Restenosis Within Three Years in Older Acute Coronary Syndrome Patients: A Two-Center Retrospective Study.
    Zhou J; Chai D; Dai Y; Wang A; Yan T; Lu S
    Clin Appl Thromb Hemost; 2022; 28():10760296221107888. PubMed ID: 35706375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation Into the Risk Factors Related to In-stent Restenosis in Elderly Patients With Coronary Heart Disease and Type 2 Diabetes Within 2 Years After the First Drug-Eluting Stent Implantation.
    Yi M; Tang WH; Xu S; Ke X; Liu Q
    Front Cardiovasc Med; 2022; 9():837330. PubMed ID: 35669469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents.
    Gai MT; Zhu B; Chen XC; Liu F; Xie X; Gao XM; Ma X; Fu ZY; Ma YT; Chen BD
    Lipids Health Dis; 2021 Sep; 20(1):118. PubMed ID: 34587955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
    Zeng M; Yan X; Wu W
    BMC Cardiovasc Disord; 2021 Sep; 21(1):446. PubMed ID: 34535088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a clinical prediction model for ischemic stroke recurrence after successful stent implantation in symptomatic intracranial atherosclerotic stenosis.
    Wang Y; Zhou Y; Hu H; Liu C; Wang P; Zhang L; Chu J; Lu Z; Guo Z; Jing W; Liu H
    J Clin Neurosci; 2024 May; 123():137-147. PubMed ID: 38574685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and validation of a clinical prediction model for asymptomatic obstructive coronary stenosis in patients with carotid stenosis.
    Qin C; Li C; Luo Y; Li Z; Cao H
    Front Cardiovasc Med; 2023; 10():1096020. PubMed ID: 37745123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictors of in-stent restenosis in coronary heart disease patients complicating with diabetes mellitus within 2 years after drug-eluting stents implantation].
    Chen J; Chen Y; Tian F; Han Y; Jing J; Liu J; Wang J; Zhou S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jan; 42(1):14-8. PubMed ID: 24680263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum apoA-I with in-stent restenosis in coronary heart disease.
    Wang X; Zhang M; Cheng J; Zhou H
    BMC Cardiovasc Disord; 2022 Aug; 22(1):355. PubMed ID: 35927634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation.
    Luo Y; Cui S; Zhang C; Huang R; Zhao J; Su K; Luo D; Li Y
    Int J Gen Med; 2022; 15():1733-1742. PubMed ID: 35221713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the Correlation Between the Ratio of Monocytes to High-Density Lipoprotein Cholesterol and in-Stent Restenosis in Patients with Premature Coronary Heart Disease.
    Chen BW; Liu JJ; Xing JH; Liu HD; Wei YZ; Xue XF; Gu HP; Tao HL
    Clin Appl Thromb Hemost; 2022; 28():10760296221079334. PubMed ID: 35187964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Atherogenic Index of Plasma Predicts Carotid in-Stent Restenosis: Development and Validation of a Nomogram.
    Zhou Y; Ma Y; Qian D; Zhou Z; Li B; Chai E
    Int J Gen Med; 2024; 17():263-274. PubMed ID: 38292824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Predictive Value of the CHA2DS2-VASc Score for In-Stent Restenosis Among Patients with Drug-Eluting Stents Implantation.
    Zhao J; Hou L; Zhu N; Huang R; Su K; Lei Y; Li Y
    Int J Gen Med; 2023; 16():69-76. PubMed ID: 36636712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a clinical prediction model for detecting coronary heart disease in middle-aged and elderly people: a diagnostic study.
    Tao S; Yu L; Yang D; Yao R; Zhang L; Huang L; Shao M
    Eur J Med Res; 2023 Sep; 28(1):375. PubMed ID: 37749613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Predictive Value of Monocyte Count to High-Density Lipoprotein Cholesterol Ratio in Restenosis After Drug-Eluting Stent Implantation.
    Nan J; Meng S; Hu H; Jia R; Chen C; Peng J; Jin Z
    Int J Gen Med; 2020; 13():1255-1263. PubMed ID: 33269001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI.
    Song T; Fu Y; Wang Y; Li W; Zhao J; Wang X; Wang H; Zhao Y; Fu X
    BMC Cardiovasc Disord; 2021 Jan; 21(1):24. PubMed ID: 33413149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of serum visfatin in predicting in-stent restenosis of drug-eluting stents.
    Wu XA; Xie G; Li XQ; Wu HT; Wang X
    Clin Chim Acta; 2018 Apr; 479():20-24. PubMed ID: 29305846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent.
    Wang JL; Qin Z; Wang ZJ; Shi DM; Liu YY; Zhao YX; Yang LX; Cheng WJ; Zhou YJ
    J Geriatr Cardiol; 2018 Feb; 15(2):137-145. PubMed ID: 29662507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.